From Aging in Place to Clinical Trials: Lowering Health Care Costs with Medication Adherence

June 29, 2016 | State of the Market Report

Medication nonadherence has a significant negative impact on disease prevention and treatment; from increasing the likelihood of preventable disease progression and hospitalizations to avoidable doctor and emergency room visits, nonadherence can adversely affect patients’ long-term health and increase costs of care. With the rapidly growing elderly population disproportionally affected by this issue, finding ways to promote better adherence can significantly reduce potential complications and allow elderly to independently age in place. In this report, we evaluate the different medication adherence technologies and how they satisfy the needs of the key stakeholders – patients, physicians, pharma, and payers. Through this analysis, we determine that smart delivery technologies stand the best chance of having a positive impact on increasing medication adherence, but still require technology improvements to achieve widespread adoption.

Coverage Areas

  • Digital Transformation
  • Emerging Ecosystems in Agrifood and Health
  • The Future of Mobility

Table of Contents

  • Executive Summary
  • Landscape
  • Analysis
  • Outlook

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978